chr7-150569934-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018326.3(GIMAP4):c.33C>A(p.Asn11Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,604,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018326.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIMAP4 | NM_018326.3 | c.33C>A | p.Asn11Lys | missense_variant | 2/3 | ENST00000255945.4 | |
GIMAP4 | NM_001363532.2 | c.33C>A | p.Asn11Lys | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIMAP4 | ENST00000255945.4 | c.33C>A | p.Asn11Lys | missense_variant | 2/3 | 1 | NM_018326.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151734Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251050Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135704
GnomAD4 exome AF: 0.0000406 AC: 59AN: 1452700Hom.: 0 Cov.: 28 AF XY: 0.0000387 AC XY: 28AN XY: 723180
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151734Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74068
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.33C>A (p.N11K) alteration is located in exon 2 (coding exon 1) of the GIMAP4 gene. This alteration results from a C to A substitution at nucleotide position 33, causing the asparagine (N) at amino acid position 11 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at